%PDF-1.6
%
1 0 obj
<>
endobj
2 0 obj
<>stream
2013-07-19T19:37:15+03:00
2013-07-19T19:37:15+03:00
2013-07-19T19:37:15+03:00
application/pdf
bs-1910R-A350
uuid:d11634ab-99d5-43cd-9fa7-b9a776e42e23
uuid:6e5a28ee-51c0-4d09-a9b9-53142de1a8b6
Acrobat Web Capture 9.0
endstream
endobj
5 0 obj
<>
endobj
6 0 obj
<>
endobj
3 0 obj
<>
endobj
7 0 obj
<>
endobj
11 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageC/ImageI]/XObject<>>>/Type/Page>>
endobj
12 0 obj
[29 0 R]
endobj
13 0 obj
<>stream
/CS0 cs 1 scn
10 815.726 574.5 -735.891 re
f
BT
0.2 scn
/TT0 1 Tf
6.6416 0 0 6.6416 21.2908 767.2422 Tm
(www.biossusa.com)Tj
0 -1.5 TD
(support@biossusa.com)Tj
-0.012 Tw 0 -1.5 TD
[(800.501.7654)-34( )1([DOMESTIC])]TJ
0 -1.5 TD
[(+1.781.569.5821)-57( )1([INTERNATIONAL])]TJ
ET
q
/GS0 gs
141.4664764 0 0 -79.6994171 438.3843994 810.412735 cm
/Im0 Do
Q
BT
0 scn
/TT1 1 Tf
0 Tw 9.2983 0 0 9.2983 21.2908 715.4376 Tm
[(bs)-67(-)-69(1910R)-12(-)-69(A350)]TJ
/TT0 1 Tf
-0.04 Tw 7.3058 0 0 7.3058 28.5965 668.9462 Tm
[(Conjugated)-58( Primary)-1( Antibodies)]TJ
/TT1 1 Tf
0 Tw 0 -2.091 TD
(Background:)Tj
/TT0 1 Tf
-0.04 Tw 0 -1.455 TD
[(Membrane)-68( Receptors)-84( )]TJ
0 -1.455 TD
[(Transforming)-35( growth)-1( factor)-4( beta)-62( is)-52( a)-20( multifunctional)-42( cytokine)-80( known)-10( to)-32( modulate)-74( several)-72( tissue)-6( development)-41( and)]TJ
0 -1.455 TD
[(repair)-83( processes,)-26( including)-72( cell)-9( differentiation,)-12( cell)-10( cycle)-7( progression,)-34( cellular)-65( migration,)-71( adhesion,)-32( and)]TJ
0 -1.455 TD
[(extracellular)-7( matrix)-35( production.)-5( There)-82( are)-44( 3)-90( forms)-38( encoded)-7( by)-40( separate)-23( genes)-27( TGFB1,)-63( TGFB2,)-63( and TGFB3.)-63( The)]TJ
T*
[(diverse)-44( effects)-71( of)-48( TGF)-46( beta)-62( are)-43( mediated)-5( by)-40( the)-36( TGF)-46( beta)-62( receptors)-73( and cell)-9( surface)-79( binding)-40( proteins.)-57( In)-69( addition)]TJ
0 -1.455 TD
[(to)-32( type)-89( I)-82( TGF)-46( beta)-62( receptor)-64( \(TGFBR1\))-70( and type)-89( II)-72( \(TFGBR2\),)-39( type)-89( III)-63( \(TGF)-27( beta)-62( III)-63( receptor\))-45( has)-16( been)]TJ
0 -1.455 TD
[(identified.)-6( It)-20( is)-52( a)-20( glycoprotein)-67( that)-67( binds)-25( TGF)-46( beta)-62( and exists)-69( in)-31( both)-12( a)-20( membrane)-90( bound)-53( and a)-20( soluble)-7( form.)-90( It)]TJ
0 -1.455 TD
[(may)-46( serve)-8( as)-29( a)-20( receptor)-64( accessory)-7( molecule)-88( in)-31( both)-12( the)-37( TGF)-46( beta)-62( and fibroblast)-1( growth)-1( factor)-4( systems.)-70( TGF)-46( beta)]TJ
0 -1.455 TD
[(III)-63( receptor)-64( lacks)-23( a)-20( recognizable)-38( signaling)-29( domain)-25( and has)-16( no)-81( clearly)-81( defined)-10( role)-69( in)-31( TGF)-46( beta)-62( signaling.)]TJ
T*
[(Endothelial)-64( cells)-18( undergoing)-9( epithelial)-62( mesenchymal)-84( transformation)-72( express)-12( TGF)-46( beta)-62( III)-63( receptor,)-34( and TGF)-46( beta)]TJ
0 -1.455 TD
[(III)-63( receptor)-64( specific)-50( antisera)-42( inhibits)-46( mesenchyme)-39( formation)-23( and migration.)-71( Misexpression)-54( of)-48( TGF)-46( beta)-62( III)]TJ
0 -1.455 TD
[(receptor)-64( in)-31( nontransforming)-81( ventricular)-89( endothelial)-8( cells)-18( conferrs)-64( transformation)-72( in)-31( response)-42( to)-32( TGFB2.)-63( These)]TJ
T*
[(results)-10( support)-17( a)-20( model)-36( where)-15( TGF)-46( beta)-62( III)-63( receptor)-64( localizes)-4( transformation)-72( in)-31( the)-37( heart)-61( and plays)-22( an)-8( essential,)]TJ
T*
[(nonredundant)-89( role)-69( in)-31( TGF)-46( beta)-62( signaling.)1( )]TJ
0 -1.455 TD
[(TGF)-46( beta)-62( III)-63( receptor,)-34( or)-6( beta)-62( glycan,)-55( can)-1( function)-77( as)-29( an)-8( inhibin)-86( coreceptor)-60( with)-46( ActRII.)-26( TGF)-46( beta)-62( III)-63( receptor)]TJ
0 -1.455 TD
[(binds)-25( inhibin)-86( with)-46( high)-11( affinity)-82( and enhances)-24( binding)-40( in)-31( cells)-18( coexpressing)-31( ActRII)-56( and TGF)-46( beta)-62( III)-63( receptor.)]TJ
0 -1.455 TD
[(Inhibin)-33( forms)-38( crosslinked)-60( complexes)-17( with)-46( both)-12( recombinant)-58( and endogenously expressed)-23( TGF)-46( beta)-62( III)-63( receptor)]TJ
0 -1.455 TD
[(and ActRII.)-26( TGF)-46( beta)-62( III)-63( receptor)-64( confers)-61( inhibin)-86( sensitivity)-37( to)-32( cell)-9( lines)-12( that)-67( otherwise)-9( respond)-6( poorly)-1( to)-32( this)]TJ
0 -1.455 TD
[(hormone.)-42( The)-59( ability)-39( of)-48( TGF)-46( beta)-62( III)-63( receptor)-64( to)-32( inhibit)-37( or)-6( to)-32( facilitate)-17( inhibin)-86( antagonism)-71( of)-48( activin)-75( provides)-19( a)]TJ
0 -1.455 TD
[(variation)-17( on)-81( the)-37( emerging)-37( roles)-78( of)-48( proteoglycans)-53( as)-29( coreceptors)-69( modulating)-78( ligand)-80( receptor)-64( sensitivity,)]TJ
T*
[(selectivity,)-23( and function.)-47( Beta)-26( arrestin)-26( 2)-90( binds)-25( to)-32( TGF)-46( beta)-62( III)-63( receptor,)-34( triggered)-6( by)-40( phosphorylation)-61( of)-48( the)]TJ
0 -1.455 TD
[(receptor)-64( on)-81( its)-82( cytoplasmic)-63( domain,)-85( likely)-64( at)-50( threonine)-81( 841.)-59( Phosphorylation)-63( is)-52( mediated)-5( by)-40( TGFBR2,)-78( which)-88( is)]TJ
0 -1.455 TD
[(itself)-9( a)-20( kinase,)-6( rather)-64( than)-25( by)-40( a)-20( G)-60( protein)-79( coupled)-31( receptor)-64( kinase.)-6( Association)-86( with)-46( beta)-62( arrestin)-26( 2)-90( leads)-85( to)]TJ
0 -1.455 TD
[(internalization)-1( of)-48( both)-12( receptors)-73( and downregulation)-7( of)-48( TGF)-46( beta)-62( signaling.)1( The)-59( regulatory)-59( actions)-86( of)-48( beta)]TJ
0 -1.455 TD
[(arrestins)-34( are)-43( broader)-34( than)-25( previously)-15( appreciated,)-7( extending)-32( to)-32( the)-37( TGF)-46( beta)-62( receptor)-64( family)-88( as)-29( well.)]TJ
/TT1 1 Tf
0 Tw 0 -1.909 TD
(Purification:)Tj
/TT0 1 Tf
-0.04 Tw 6.727 -0.091 Td
[(Was)-36( purified)-38( by)-40( Protein)-81( A)-36( and peptide)-90( affinity)-82( chromatography.)]TJ
/TT1 1 Tf
0 Tw -6.727 -2 Td
(Storage:)Tj
/TT0 1 Tf
-0.04 Tw 0 -1.455 TD
[(Prepared)-46( as)-29( lyophilized)-45( powder)-87( or)-6( liquid)-13( and shipped)-37( on)-81( ice.)-26( Store)-44( at)-50( -)-1(20\260C)-18( for)-52( one)-9( year.)-61( Protect)-73( from)-30( light.)]TJ
/TT1 1 Tf
0 Tw 0 -1.909 TD
(Reconstitution:)Tj
/TT0 1 Tf
-0.04 Tw 0 -1.455 TD
[(If)-36( the)-36( antibody)-25( is)-52( in)-31( liquid)-13( form,)-91( no)-81( reconstitution)-78( needed.)]TJ
0 -2.909 TD
[(Reconstitution)-90( is)-52( only)-81( required)-62( for)-52( the)-36( lyophilized)-45( antibody.)-86( Please)-15( refer)-92( to)-32( the)-37( reconstitution)-78( instruction)-26( card)-10( in)]TJ
0 -1.455 TD
[(the)-36( package.)]TJ
/TT1 1 Tf
0 Tw 54.182 54.545 Td
(Size:)Tj
/TT0 1 Tf
-0.04 Tw 3 -0.091 Td
[(100ul)-29( or)-6( 100ug)-69( lyophilized)]TJ
/TT1 1 Tf
0 Tw -3 -2.818 Td
(Concentration:)Tj
/TT0 1 Tf
8.091 -0.091 Td
(1ug/uL)Tj
/TT1 1 Tf
-8.091 -2.818 Td
(Host:)Tj
/TT0 1 Tf
3.273 -0.091 Td
(Rabbit)Tj
/TT1 1 Tf
-3.273 -1.909 Td
(Reactivities:)Tj
0.2 scn
/TT0 1 Tf
6.6416 0 0 6.6416 424.437 623.1191 Tm
(Human,Mouse,Rat,Chicken,Dog,Pig,Sheep,)Tj
0 scn
/TT1 1 Tf
7.3058 0 0 7.3058 424.437 609.1717 Tm
(Application:)Tj
ET
q
10 36 575 780 re
W n
q 1 0 0 1 434.3994 591.5714 cm
0 0 m
0 1.328 -1.992 1.328 -1.992 0 c
-1.992 -1.328 0 -1.328 0 0 c
f
Q
Q
BT
/TT0 1 Tf
7.3058 0 0 7.3058 441.041 589.911 Tm
[(IF\(1:100)-3(-)-1(500\))]TJ
ET
q
10 36 575 780 re
W n
q 1 0 0 1 434.3994 580.9448 cm
0 0 m
0 1.328 -1.992 1.328 -1.992 0 c
-1.992 -1.328 0 -1.328 0 0 c
f
Q
Q
BT
/TT0 1 Tf
-0.04 Tw 7.3058 0 0 7.3058 441.041 579.2844 Tm
[(Not)-1( yet)-6( tested)-8( in)-31( other)-43( applications.)]TJ
0 -1.455 TD
[(Optimal)-36( working)-62( dilutions)-48( must)-4( be)]TJ
0 -1.455 TD
[(determined)-86( by)-40( the)-36( end)-90( user.)]TJ
/TT1 1 Tf
-0.02 Tw -2.273 -3.818 Td
[(Antibody)-48( Type:)]TJ
/TT0 1 Tf
0 Tw 8.182 -0.091 Td
(Polyclonal)Tj
/TT1 1 Tf
-8.182 -1.909 Td
(Isotype:)Tj
0.2 scn
/TT0 1 Tf
6.6416 0 0 6.6416 467.6075 515.5248 Tm
(IgG)Tj
0 scn
/TT1 1 Tf
-0.02 Tw 7.3058 0 0 7.3058 424.437 501.5775 Tm
[(Molecular)-1( Weight:)]TJ
0.2 scn
/TT0 1 Tf
0 Tw 6.6416 0 0 6.6416 503.4723 501.5775 Tm
(94kDa)Tj
0 scn
/TT1 1 Tf
7.3058 0 0 7.3058 424.437 487.6301 Tm
(Preservatives:)Tj
0.2 scn
/TT0 1 Tf
-0.012 Tw 6.6416 0 0 6.6416 424.437 477.6676 Tm
[(10ug/uL)-59( )1(BSA)-54( )1(and)-64( )1(0.1%)-28( )1(NaN3.)]TJ
0 scn
0.021 Tw 5.9775 0 0 5.9775 424.437 450.437 Tm
[(For)-20( )1(research)-16( )1(use)-25( )1(only.)-91( )1(CAUTION:)-13( )1(Not)-12( )1(for)-1( )1(human)-72( )1(or)]TJ
0 -1.333 TD
[(animal)-94( )1(therapeutic)-36( )1(or)-97( )1(diagnostic)-13( )1(use.)]TJ
ET
q
/GS0 gs
564.5375671 0 0 -0.6641693 15.3132935 706.8034821 cm
/Im1 Do
Q
BT
/TT0 1 Tf
0 Tw 10.6266 0 0 10.6266 21.2908 81.8272 Tm
( )Tj
ET
q
10 36 575 780 re
W n
/CS3 cs 0.302 0.306 0.333 scn
q 1 0 0 1 19.2983 691.5278 cm
0 0 m
0 1.771 -2.657 1.771 -2.657 0 c
-2.657 -1.771 0 -1.771 0 0 c
f
Q
Q
BT
/CS3 cs 0.302 0.306 0.333 scn
/TT1 1 Tf
-0.007 Tw 9.2983 0 0 9.2983 28.5965 688.8711 Tm
[(Rabbit)-50( Anti)-28(-)-69(TGF)-62( Beta)-62( R3)-65( Polyclonal)-4( Antibody,)-47( Alexa)-2( Fluor)-69( 350)-18( conjugated)]TJ
/CS0 cs 0 scn
/TT0 1 Tf
0 Tw 10.6266 0 0 10.6266 25.2757 254.5092 Tm
( )Tj
12.063 0 Td
( )Tj
12.125 0 Td
( )Tj
-24.188 -2.25 Td
( )Tj
12.063 0 Td
( )Tj
12.125 0 Td
( )Tj
-24.188 -2.25 Td
( )Tj
12.063 0 Td
( )Tj
12.125 0 Td
( )Tj
-0.04 Tw 7.3058 0 0 7.3058 26.604 174.8098 Tm
[(For)-30( full)-30( size)-82( images)-63( and description)-26( please)-13( click)-31( )]TJ
/CS3 cs 0 0.6 0.8 scn
0 Tw 6.6416 0 0 6.6416 180.6896 174.8098 Tm
(HERE)Tj
/CS0 cs 0 scn
7.3058 0 0 7.3058 197.2936 174.8098 Tm
(.)Tj
ET
q
/GS0 gs
0.6641693 0 0 -597.7456512 410.4896088 706.1392975 cm
/Im2 Do
Q
q
/GS0 gs
5.9774628 0 0 -40.5138702 569.888443 120.3485565 cm
/Im3 Do
Q
endstream
endobj
14 0 obj
<>
endobj
15 0 obj
(y7 K<J)
endobj
25 0 obj
<>stream
Hy\E323#3
P̴,HLEK"+E+2VTD%EH# }wfwfvvc_3?{feޝ@HHHHHH*豘V]
zן)@-9.q2BÇEڂ8g "2vn>u2]/Yz \S@ 7.M&p?o9v 0'rKś-;(Au.J%% %&˶0>6`TxOzzo(VDY*AZp ËgAs^.㮌+2Ȱ$E['FC:OMCIVVDD3}`u߈buߨɴ4қԭV^V0XF ϓ@i|Y|.?i'3}Ŵ+ޘaa:
3g},F"kNɳՕx57,H)X7*v/Mո+(fWr=WӃJcߓtG16sPt:t"9G
if
3do\ˢ|c:1&<ЭWnPdq0IRgu~惘n9BWV2T6~}rs4h-D.sgV/n3;q@hThI*jTJqJK2c!QT7;60
5NoJݻ'rBP%ȍ4
P(/CJC1
9eڴ}5S{"wty@P5e*Zg~?S(Sɗ,ʽv 2[̋t_Z\d&}/2YϹO&y#
?P>,0P-
asds[U꼩\=T~)S>B,gk$7+j0?60<&uźg
A]_@en%Mȝ~5PSu$^2s0RSPw L9٦n9$vڣ=f#g 7,Oa
:ܾ.4+H!=MvF(G|YU
ITR)>@✧*[j5KoB{Kp,`姙$JO궒jvż@r3`w\A%jSx+>m;5ا@._1:T#q]wrTC8r:lU4P}~Y]XwJ~b:YQϗLP-X_ֻа2$ݥC=~P]VҘLhu?S'\C:7"4dD*%9 Ogfe\OLoTy5Qkj.84,: t:_YON3˃:O/r犁3t!Psbty{aETu7nMѶ f+^Y6zHic?R%+C,γL =ZJ1H+,x^
I!u2{5x_@LI6[w5LN5:xXoEgf9tu=yùw=aґza*҃K`驪eP/y*sσn3N{ME\8g: *fz#W??L